Cargando…
Combining proteomic markers to construct a logistic regression model for polycystic ovary syndrome
INTRODUCTION: Proteomics technology has been used in various fields in recent years for the Q6 exploration of novel markers and the study of disease pathogenesis, and has become one of the most important tools for researchers to explore unknown areas. However, there are fewer studies related to the...
Autores principales: | Tong, Cheng, Wu, Yue, Zhuang, Zhenchao, Wang, Zhejiong, Yu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579946/ https://www.ncbi.nlm.nih.gov/pubmed/37854181 http://dx.doi.org/10.3389/fendo.2023.1227252 |
Ejemplares similares
-
Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome
por: Yu, Ying, et al.
Publicado: (2021) -
Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019) -
The Lifestyle Modifications and Endometrial Proteome Changes of Women With Polycystic Ovary Syndrome and Obesity
por: Abdulkhalikova, D., et al.
Publicado: (2022) -
The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019) -
Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome
por: Feng, Di, et al.
Publicado: (2019)